3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Uveal Melanoma
2
Lymphoma, T-Cell, Cutaneous
2
Lichen Planus, Oral
2
Stomach Neoplasms
1
Retinal Diseases
1
Recurrence
1
Radiodermatitis
1
Pancreatitis, Chronic
1
Pancreatic Neoplasms
1
Pain
1
Neuroma, Acoustic
1
Mycosis Fungoides
1
Melanoma
1
Macular Degeneration
1
Lymphomatoid Papulosis
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Leiomyoma
1
Glioblastoma
1
Fibroma
1
Exanthema
1
Esophageal Stenosis Acquired
1
Dupuytren Contracture
1
Disease
1
Dermatitis, Contact
1
Choroid Diseases
1
Chalazion
1
Castration Resistant Prostate Cancer
1
Interventions
Ranibizumab
2
salicylhydroxamic acid
1
Triamcinolone Acetonide
1
Standard of Care
1
Hematopoietic Stem Cell Transplantation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Retinal Diseases
×
Triamcinolone Acetonide
×
Clear all
NCT00811200
2009-07-02
TORR
Leiden University Medical Center
Phase 2/3
Unknown
220 enrolled